Sai Parenteral's Limited - Company Profile

It is a pharma public limited company based in Seri Lingampally, Telangana, India, established in 2001.
2001 Seri Lingampally, Telangana, India Active
Last Updated:
Access Report
About Sai Parenteral's Limited

Sai Parenteral's Limited, a active public limited company, was established on 12 January 2001 in Seri Lingampally, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231TG2001PLC036043. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹25.76 Cr and a paid-up capital of ₹18.45 Cr.

Formerly known as Sai Parenteral's Private Limited. It upholds a compliant status. Employing 235 professional, Its leadership includes Kalidindi Venkateswara Raju (Director), Bhagyashri Dharmasa Zad (Director), Aruna Karusala (Director). Past directors included Vishveshwar Raj Saxena, Aruna Karusala, Sarup Raj Saxena. It holds ₹213.36 Cr open charges and ₹121.89 Cr settled loans. Its latest AGM occurred on 27 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No 39, 5Th Floor, Lavanya Arcade Jayabheri Enclave, Gachibowli, Seri Lingampally, Telangana, 500032.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231TG2001PLC036043

  • Registration Number

    036043

  • Incorporation Date

    12 January 2001

  • Authorized Capital

    ₹25.76 Cr

  • Paid-Up Capital

    ₹18.45 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 25.76 Cr
  • Paid Up Capital ₹ 18.45 Cr
  • Company Age 25 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 213.36 Cr
  • Satisfied Charges ₹ 121.89 Cr
  • Revenue Growth **** 7.73%
  • Profit Growth **** -45.35%
  • Ebitda **** 15.85%
  • Net Worth 29.52%
  • Total Assets **** 49.16%
Company report

Sai Parenteral's Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sai Parenteral's Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sai Parenteral's Limited?
Current Directors
Name Designation Appointment Date Status
Kalidindi Venkateswara Raju Director 12 Nov 2024 Current
Bhagyashri Dharmasa Zad Director 01 Jan 2024 Current
Aruna Karusala Director 16 Aug 2016 Current
Anil Kumar Karusala Managing Director 19 Nov 2021 Current
Seeta Ram Anjaneyulu Gorantla Director 01 Jan 2024 Current
Vijitha Gorrepati Whole-Time Director 16 Aug 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Feb 2010 Past
Pramod Abcsdd Additional Director 29 Sep 2016 Past
Pramod Abcsdd Managing Director 12 Sep 2016 Past
Pramod Abcsdd Additional Director 15 Dec 2021 Past
Pramod Abcsdd Director 12 Sep 2016 Past
Pramod Abcsdd Cfo 31 Oct 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sai Parenteral'S.

Sai Parenteral'S Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.73% increase. The company also saw a substantial fall in profitability, with a 45.35% decrease in profit. The company's net worth Soared by an impressive increase of 29.52%.

Sai Parenteral'S revenue growth over time
Sai Parenteral'S profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 7.73%
*******
*******
*******
*******
Revenue from Operations
*******
 8.54%
*******
*******
*******
*******
Total Assets
*******
 49.16%
*******
*******
*******
*******
Profit or Loss
*******
 -45.35%
*******
*******
*******
*******
Net Worth
*******
 29.52%
*******
*******
*******
*******
EBITDA
*******
 15.85%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sai Parenteral'S?

In 2022, Sai Parenteral'S had a promoter holding of 83.92% and a public holding of 16.08%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,133,600,000.00

Satisfied Charges

₹1,218,915,454.00

Charges Breakdown by Lending Institutions
  • Others : 105.51 Cr
  • Axis Bank Limited : 61.00 Cr
  • The Hongkong And Shanghai Banking Corporation Limited : 24.25 Cr
  • Hdfc Bank Limited : 20.00 Cr
  • Sidbi : 2.60 Cr
Latest Charge Details
Date Lender Amount Status
17 Dec 2025 Others ₹38.00 Cr Open
11 Dec 2025 Axis Bank Limited ₹61.00 Cr Open
08 Dec 2025 The Hongkong And Shanghai Banking Corporation Limited ₹1.25 Cr Open
29 Aug 2025 Others ₹20.00 Cr Open
30 Oct 2024 Others ₹47.51 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Sai Parenteral'S?

Sai Parenteral'S has a workforce of 235 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sai Parenteral'S, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sai Parenteral'S's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sai Parenteral'S
Recent Activity within the Organization
  • Charges

    The activity A charge with Others amounted to Rs. 38.00 Cr with Charge ID 101210350 was registered on 17 Dec 2025. was completed.

  • Charges

    Progress on A charge with Axis Bank Limited amounted to Rs. 61.00 Cr with Charge ID 101210375 was registered on 11 Dec 2025. was documented.

  • Charges

    The activity A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 1.25 Cr with Charge ID 101206434 was registered on 08 Dec 2025. was completed.

  • Charges

    The activity A charge with Others of Rs. 20.00 Cr registered on 29 Aug 2025 with Charge ID 101149137 was modified on 03 Oct 2025. was completed.

  • Director Appointment

    Anil Kumar was appointed as a Cfo was appointed as a Cfo on 01 Oct 2025 & has been associated with this company since 5 months 12 days . was recorded as a recent event.

  • Annual General Meeting

    Progress on Sai Parenteral'S Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sai Parenteral's Limited?

The CIN of Sai Parenteral's Limited is U24231TG2001PLC036043.

Where is Sai Parenteral's Limited headquartered?

Sai Parenteral's Limited is headquartered at Plot No 39, 5Th Floor, Lavanya Arcade Jayabheri Enclave, Gachibowli, Seri Lingampally, Telangana, 500032.

When was Sai Parenteral's Limited incorporated?

Sai Parenteral's Limited was incorporated on 12 January 2001.

Who are the current directors of Sai Parenteral's Limited?

The current directors of Sai Parenteral's Limited are

What is the primary industry of Sai Parenteral's Limited?

The primary industry of Sai Parenteral's Limited is Manufacturing.

Is Sai Parenteral's Limited a listed company?

Sai Parenteral's Limited is unlisted.

What is the capital structure of Sai Parenteral's Limited?

The authorized capital of Sai Parenteral's Limited is ₹25.76 Cr, and the paid-up capital is ₹18.45 Cr.

What is the compliance status of Sai Parenteral's Limited?

The compliance status of Sai Parenteral's Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available